Abzu is the best in class in silico disease understanding and drug design company. Since its founding in 2018, Abzu’s proprietary explainable AI, the QLattice®, has been the cornerstone to their cutting-edge approach. Abzu is a preferred partner for pharma, biotech, and research institutions, transforming data into insights and accelerating R&D.
Abzu has offices in Copenhagen and Barcelona, and has raised €13.3M in total funding to date. Abzu has been mentioned in Gartner® research, from Market Guides for AI Trust, Risk, and Security Management to Cool Vendor™, and is the winner of several awards, including the 2023 “Best HealthTech” Nordics Award at the Nordic Startup Awards.
Company Details
- Employees
- 24
- Founded
- -
- Address
- Orient Plads 1, Mezzanine,denmark
- Phone
- 4529298524
- in****@****abzu.ai
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- abzu.ai
- Keywords
- RNA Therapeutics, RNA Tx, AI, artificial intelligence, explainable AI, trustworthy AI, QLattice, drug development, pharma, pharma R&D.
- HQ
- Nordhavn, Capital Region
Abzu Questions
Abzu's helpline number is 4529298524
Abzu's website is abzu.ai
Abzu's LinkedIn profile is https://dk.linkedin.com/company/abzu
Abzu has
24 employees.
View email and phone details for 24
employees at Abzu.
Abzu's industry is
Biotechnology Research
Abzu's top competitors are
Genmab,
Radiobotics,
Lightpost One,
Exektek,
Corti,
Contera Pharma,
Heqet Therapeutics,
Aves Aps,
Scientek,
Roche.
Abzu's support email address is info@abzu.ai
Abzu's categories are Biotechnology Research
Abzu's founding year is 2018
